Patents by Inventor Preeti Bais

Preeti Bais has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarkers of autism spectrum disorder
    Patent number: 11268966
    Abstract: Methods for identifying metabolic signatures in blood plasma which are unique to autism are described herein. Samples are analyzed using multiple chromatographic-mass spectrometry-based techniques to orthogonally measure a broad range of small molecular weight metabolites differentially produced in autistic patient samples versus non-autistic control samples. These individual metabolites or a panel of such metabolites serve as metabolic signatures of autism. Such metabolic signatures are used in diagnostic methods to accurately identify individuals with autism spectrum disorder (ASD).
    Type: Grant
    Filed: July 27, 2018
    Date of Patent: March 8, 2022
    Assignee: Stemina Biomarker Discovery, Inc.
    Inventors: Paul West, Robert E. Burrier, Laura Egnash, Alan Smith, Preeti Bais
  • BIOMARKERS OF AUTISM SPECTRUM DISORDER
    Publication number: 20190072569
    Abstract: Methods for identifying metabolic signatures in blood plasma which are unique to autism are described herein. Samples are analyzed using multiple chromatographic-mass spectrometry-based techniques to orthogonally measure a broad range of small molecular weight metabolites differentially produced in autistic patient samples versus non-autistic control samples. These individual metabolites or a panel of such metabolites serve as metabolic signatures of autism. Such metabolic signatures are used in diagnostic methods to accurately identify individuals with autism spectrum disorder (ASD).
    Type: Application
    Filed: July 27, 2018
    Publication date: March 7, 2019
    Inventors: Paul West, Robert E. Burrier, Laura Egnash, Alan Smith, Preeti Bais
  • Biomarkers of autism spectrum disorder
    Patent number: 10060932
    Abstract: Methods for identifying metabolic signatures in blood plasma which are unique to autism are described herein. Samples are analyzed using multiple chromatographic-mass spectrometry-based techniques to orthogonally measure a broad range of small molecular weight metabolites differentially produced in autistic patient samples versus non-autistic control samples. These individual metabolites or a panel of such metabolites serve as metabolic signatures of autism. Such metabolic signatures are used in diagnostic methods to accurately identify individuals with autism spectrum disorder (ASD).
    Type: Grant
    Filed: July 3, 2014
    Date of Patent: August 28, 2018
    Assignee: Stemina Biomarker Discovery, Inc.
    Inventors: Paul West, Robert E. Burrier, Laura Egnash, Alan Smith, Preeti Bais
  • BIOMARKERS OF AUTISM SPECTRUM DISORDER
    Publication number: 20160169915
    Abstract: Methods for identifying metabolic signatures in blood plasma which are unique to autism are described herein. Samples are analyzed using multiple chromatographic-mass spectrometry-based techniques to orthogonally measure a broad range of small molecular weight metabolites differentially produced in autistic patient samples versus non-autistic control samples. These individual metabolites or a panel of such metabolites serve as metabolic signatures of autism. Such metabolic signatures are used in diagnostic methods to accurately identify individuals with autism spectrum disorder (ASD).
    Type: Application
    Filed: July 3, 2014
    Publication date: June 16, 2016
    Inventors: Paul West, Robert E. Burrier, Laura Egnash, Alan Smith, Preeti Bais